Abstract

Electrooxidation has emerged as an increasingly viable platform in molecular syntheses that can avoid stoichiometric chemical redox agents. Despite major progress in electrochemical C−H activations, these arene functionalizations generally require directing groups to enable the C−H activation. The installation and removal of these directing groups call for additional synthesis steps, which jeopardizes the inherent efficacy of the electrochemical C−H activation approach, leading to undesired waste with reduced step and atom economy. In sharp contrast, herein we present palladium-electrochemical C−H olefinations of simple arenes devoid of exogenous directing groups. The robust electrocatalysis protocol proved amenable to a wide range of both electron-rich and electron-deficient arenes under exceedingly mild reaction conditions, avoiding chemical oxidants. This study points to an interesting approach of two electrochemical transformations for the success of outstanding levels of position-selectivities in direct olefinations of electron-rich anisoles. A physical organic parameter-based machine learning model was developed to predict position-selectivity in electrochemical C−H olefinations. Furthermore, late-stage functionalizations set the stage for the direct C−H olefinations of structurally complex pharmaceutically relevant compounds, thereby avoiding protection and directing group manipulations.

Electrochemistry has emerged as an increasingly viable tool in molecular synthesis. Here the authors realize electrocatalyzed C−H activations, with the aid of data science and artificial intelligence, towards selective alkenylations for late-stage drug diversifications.

Details

Title
Electrocatalyzed direct arene alkenylations without directing groups for selective late-stage drug diversification
Author
Lin, Zhipeng 1 ; Dhawa, Uttam 1   VIAFID ORCID Logo  ; Hou, Xiaoyan 1 ; Surke, Max 1 ; Yuan, Binbin 1 ; Li, Shu-Wen 2   VIAFID ORCID Logo  ; Liou, Yan-Cheng 1 ; Johansson, Magnus J. 3   VIAFID ORCID Logo  ; Xu, Li-Cheng 2 ; Chao, Chen-Hang 2 ; Hong, Xin 4 ; Ackermann, Lutz 5   VIAFID ORCID Logo 

 Georg-August-Universität Göttingen, Wöhler Research Institute for Sustainable Chemistry (WISCh), Göttingen, Germany (GRID:grid.7450.6) (ISNI:0000 0001 2364 4210) 
 Zhejiang University, Center of Chemistry for Frontier Technologies, Department of Chemistry, State Key Laboratory of Clean Energy Utilization, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
 AstraZeneca, Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, Gothenburg, Sweden (GRID:grid.418151.8) (ISNI:0000 0001 1519 6403); Stockholm University, Department of Organic Chemistry, Stockholm, Sweden (GRID:grid.10548.38) (ISNI:0000 0004 1936 9377) 
 Zhejiang University, Center of Chemistry for Frontier Technologies, Department of Chemistry, State Key Laboratory of Clean Energy Utilization, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X); Beijing National Laboratory for Molecular Sciences, Beijing, PR China (GRID:grid.454727.7); Westlake University, Key Laboratory of Precise Synthesis of Functional Molecules of Zhejiang Province, School of Science, Hangzhou, China (GRID:grid.494629.4) (ISNI:0000 0004 8008 9315) 
 Georg-August-Universität Göttingen, Wöhler Research Institute for Sustainable Chemistry (WISCh), Göttingen, Germany (GRID:grid.7450.6) (ISNI:0000 0001 2364 4210); German Centre for Cardiovascular Research (DZHK), Berlin, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237) 
Pages
4224
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2837648432
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.